Rudnicki, M. (2017). Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. Biomed Res Int.
Style de citation ChicagoRudnicki, Michael. "Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies." Biomed Res Int 2017.
Style de citation MLARudnicki, Michael. "Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies." Biomed Res Int 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.